Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Catheter Precision, Inc. Director's Dealing 2026

Jan 20, 2026

35479_dirs_2026-01-20_677e64f1-1d66-4bab-8fa9-63e3aebf8e05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2025-12-31

Reporting Person: JENKINS DAVID A (Chairman of the Board and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-31 Series M Common Stock Purchase Warrant $1.56 J 170000 Acquired Common Stock (170000) Direct
2025-12-31 Series M Common Stock Purchase Warrant $1.56 J 170000 Acquired Common Stock (170000) Indirect

Footnotes

F1: Initial Exercise Date is any time on or after the Stockholder Approval Date.

F2: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date

F3: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP